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ABSTRACT
Background: Despite the difference in geographical dominance of certain grasses, a high degree of aller-
genic similarity or cross-reactivity between Bermuda grass pollen (BGP) and timothy grass pollen (TGP) has
been previously demonstrated.
The aim of the present study was to ascertain the sensitisation to TGP in 411 patients known for their reactiv-
ity to BGP extracts by analysing their reactivity to crude timothy pollen extract and timothy pollen purified aller-
gens, establishing their specific IgE-profiles.
Methods: Using the immunoenzymatic CAP method we evaluated IgE-specific antibodies for BGP- and TGP-
extracts and the timothy recombinant (r) and natural (n) allergens rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6,
rPhl p 7, rPhl p 11, and rPhl p 12.
Results: BGP-IgE positive patients (median = 8.0 kUAl, 2.8―22.2 kUAl 25th―75th percentile) simultaneously
had IgE positive results for TGP (100% of subjects) (median = 48.9 kUAl, 19.8― > 100 kUAl 25th―75th percen-
tile) and high prevalence of sensitization to 68 Phleum pratense allergens (Phl p 1, 2, 4, 5, 6, 11, markers of
genuine sensitisation to TGP) other than profilin and calcium binding protein. More than 72% of BGP allergic
patients were co-sensitised to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6. A decrease of total and specific IgE
with patients’ age was observed.
Conclusions: Our data show that all BGP-allergic patients simultaneously exhibit higher IgE antibody levels
to recombinant and natural P. pratense allergens as well as to crude TGP extract. This suggests that when
choosing an immunotherapeutic regimen for BGP-sensitised patients (after establishing their IgE profile via pu-
rified TGP-allergens), subcutaneous or sublingual TGP-extract vaccines in appropriate doses, in order to influ-
ence T epitope specificity, might be beneficial. Though extremely uncommon, in cases where a patient is exclu-
sively BGP allergen-sensitised, BGP-extract therapy is the appropriate therapeutic response.
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INTRODUCTION
Grass pollens are a common cause of respiratory al-
lergy in the industrialized world but a limited number
of grass species are recognized as major causes of
respiratory symptoms. Those affected by grass pollen
sensitization are believed to account for as much as
20% of the general population and up to 40% of the
atopic population.
Grasses are the group of plants studied in most de-
tail, which are confined to a single taxonomic family,
Poaceae. Up to now 71 allergens from 15 species dis-
tributed among 10 protein families have been isolated
and the most relevant grass pollen allergens have al-
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Table 1 Clinical picture of 411 patients with specific IgE to Cynodon dactylon and Phleum pratense extracts, aranged by age 
decade
＞60＜71 yrs
(N＝9)
＞50＜61 yrs
(N＝14)
＞40＜51 yrs
(N＝22)
＞30＜41 yrs
(N＝63)
＞20＜31 yrs
(N＝93)
＞10＜21 yrs
(N＝123)
＜11 yrs
(N＝87)Symptoms
77.7 %
(N＝7)
78.5%
N＝11
72.7%
N＝16
71.4%
N＝45
74.1%
N＝69
69.9%
N＝86
65.5%
N＝57Rhinoconjunctivitis
28.3%
N＝2
21.5%
N＝4
27.3%
N＝6
28.6%
N＝18
25.8%
N＝24
29.1%
N＝37
34.5%
N＝30Asthma
11.1%
(N＝1)
 7.1%
(N＝1)
13.6%
(N＝3)
 9.5%
(N＝6)
 8.6%
(N＝8)
 8.1%
(N＝10)
 4.6%
(N＝4)Oral Alergy Syndrome
ready been identified.1
In allergy diagnosis and allergen extract-based im-
munotherapy, pollen extracts from about 20 grasses
are currently employed. Andersson and Lidholm re-
ported that, Phleum pratense and twelve other grasses
(Anthoxatum, Dactylis, Festuca, Lolium, Poa, Agrostis,
Bromus, Secale, Holcus, Avena, Triticum, Alopecurus)
contain homologous allergen components.2 Their
study also showed that four species (Cynodon dacty-
lon, Phragmites communis, Sorghum halepense and
Paspalum notatum), stood out as different from the
corresponding data for P. pratense, but when the two
groups were then plotted against each other, two spe-
cies (S. halepense and P. notatum) were found to be
similar.
Pure natural or recombinant allergens are cur-
rently used in diagnostic tests.3,4
Bermuda grass (Cynodon dactylon) pollen (BGP) is
one of the most common causes of airway allergic
disease, and has been shown to contain over 12 aller-
genic proteins (i.e. Cyn d 1, 2, 4, 5, 6, 7, 10, 11, 12, 13,
15, 22, 23) on 1-D immunoglobulin E (IgE) im-
munoblots.5,6 However, of these allergens only a few
have been identified and characterized. Recently, a
pathogenesis-related protein 1, Cyn d 24, was identi-
fied from BGP.7 Despite the difference in geographi-
cal dominance of certain grasses, there are extensive
studies2,5,8 highlighting a high degree of allergenic
similarity or cross-reactivity between BGP and timo-
thy grass pollen (TGP). In the present study, we se-
lected a large number of patients already known to be
sensitized to BGP and their IgE profiles were evalu-
ated with a panel of TGP allergen molecules.
METHODS
STUDY POPULATION
This retrospective study used the sera of 411 con-
secutive patients, mean age 22.7 years, range 2―67
years, with specific IgE towards BGP extract >0.7
kUAl. All subjects lived in or near the city of Cuneo
in north-western Italy, and therefore presumably
were exposed to the same allergen sources. The pa-
tients had a history of seasonal (April―July) pollen al-
lergy with symptoms of rhinitis (n = 273) andor
asthma (n = 138). A fraction of them (n = 33) suffered
from oral allergy syndrome after eating fruit (OAS).
None of the patients had received any form of specific
immunotherapy to pollen extracts, although some re-
ceived topical steroids, antihistamines and antileukot-
rines. The patients’ clinical picture, arranged by age
decade is shown in Table 1.
DETERMINATION OF ALLERGEN-SPECIFIC IGE
ANTIBODIES
IgE-specific antibodies for BGP-, TGP-extracts and
the timothy recombinant (r) and natural (n) allergens
rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p
7, rPhl p 11, and rPhl p 12 were evaluated using the
immunoenzymatic CAP method (Phadia, Uppsala,
Sweden) according to the manufacturer’s instruc-
tions. The results were expressed in classes of posi-
tivity from 0 to 6, where class 0 corresponds to <0.35
kUAl; class 1 0.35―0.7 kUAl; class 2 0.7―3.5 kUAl;
class 3 3.5―17.5 kUAl; class 4 17.5―50 kUAl; class 5
50―100 kUAl; and class 6 >100 kUAl.
STATISTICAL ANALYSIS
Nonparametric statistical methods were used. The
Mann-Whitney U test was used for comparison of the
two unpaired groups. The correlation index (r) was
determined with the Spearman rank correlation coef-
ficient matrix. Patients were also evaluated with a
mixed design analysis of variance (ANOVA). P < 0.05
was considered to indicate significant differences.
RESULTS
Patients in our study were selected for their known
reactivity to BGP extracts and were further character-
ized by their reactivity to crude timothy pollen ex-
tract; in fact 100% of our subjects tested positive to
TGB. Moreover, those patients who had detectable
serum IgE levels towards BGP (median = 8.0 kUAl,
2.8―22.2 kUAl 25th―75th percentile) simultaneously
had higher TGP IgE levels (median = 48.9 kUAl,
19.8― > 100 kUAl 25th―75th percentile). In addition,
BGP positive patients had a high prevalence of sensi-
tization to 68 P. pratense allergens other than profilin
and calcium binding protein (more than 68%) (Fig. 1).
Furthermore, in BGPTGP-double positive patients
the values obtained through the sum of the individual
Specific IgE to Grass Pollen Allergens
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Fig. 1 Frequency of sensitisation to timothy alergens in 411 patients sensitised to Bermuda grass polen (Cynodon 
dactylon).
Cyn d e, Cynodon dactylon extract; Phl p e, Phleum pratense extract.
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Fig. 2 Median value of specific IgE to Cynodon dactylon extract (Cyn d 
E)(median＝6.68 kUA/l, 2.8―18.2, 25th―75th percentile), Phleum pratense 
extract (Phl p E)(median＝42.4 kUA/l, 19―84.8, 25th―75th percentile), and 
the sum of single values of specific IgE towards rPhl p 1, rPhl p 2, nPhl 4, 
rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, rPhl p 12 (rSUM)(median＝ 63.9 
kUA/l, 27.5― 129.6, 25th― 75th percentile), in 411 Bermuda grass alergic 
patients.
660.0
495.1275
330.255
165.3825
0.51
p＜0.001
p＜0.001
Cyn d '
KUA/L
Phl p ' rSUM
p＜0.001
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Fig. 3 Median value of specific IgE to Cynodon dactylon extract (Cyn d E), Phleum prat
ense extract Phl p E) and single values of specific IgE towards rPhl p 1, rPhl p 2, nPhl 4, 
rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, rPhl p 12 in 411 Bermuda grass alergic patients.
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Fig. 4 Eight Phleum pratense alergens which contribute to the total sum of its IgE value, shown 
here in their percentage representations.
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TGP allergen IgE levels (Phl p 1, 2, 4, 5, 6, 7, 11, 12)
were almost twice higher than TGP-IgE levels and ap-
proximately 8 times higher than BGP IgE levels (Fig.
2). Serum specific IgE levels of the 8 TGP allergens
are shown in Figure 3. Variations of total and specific
serum IgE concentrations were observed depending
on patients’ ages (Figs. 4―7) with the exception of Phl
p 7. Comparisons of different variables as viewed
across 10-year age increments are shown in Table 2
and Figures 4―6.
Of 411 BGPTGP-positive subjects 298 (72.50%)
were co-sensitised to rPhl p 1, rPhl p 2, nPhl p 4, rPhl
p 5, rPhl p 6. The two main patient IgE profiles with
relative prevalence in different age decades are de-
picted in Table 3. The sum of the specific IgE levels
to P. pratense allergens within the study population is
to a certain extent determined by Phl p 1 and Phl p 5
IgE values as is shown in Figure 4.
Specific IgE to Grass Pollen Allergens
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Fig. 5 Total IgE; Cynodon dactylon-extract specific (Cyn d E) IgE; Phleum pratense-extract specific (Phl p E) IgE; sum of Phl 
p (1, 2, 4, 5, 6, 7, 11, 12)-IgE value variation, in 411 Bermuda grass polen alergic patients, shown by age (y＝years).
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The sum value of specific IgE directed to TPB aller-
gens is correlated as follows: IgE, r = 0.6 49781 (P <
0.0001); BGP, r = 0.844994 (P < 0.0001); TGP, r =
0.962687 (P < 0.0001); patient age (inversely corre-
lated), r = −0.38641 (P < 0.0001). Out of 33 patients
suffering from OAS after eating fruits and vegetables,
28 were sensitised to profilin (the remaining 5 pa-
tients with OAS were co-sensitised to the birch pollen
major allergen Bet v 1).
DISCUSSION
In this study we documented that 411 consecutive pa-
tients with BGP-extract IgE positive results simulta-
neously had TGP-extract IgE positive results. Despite
not having performed an IgE inhibition analysis of
these patients’ sera (this was a retrospective study)
the selection of patients on the basis of their IgE posi-
tivity to BGP revealed that these same patients had si-
multaneous and higher specific IgE antibodies to-
wards TGP allergens with respect to BGP specific
IgE levels. This would seem to reinforce our premise
that the presence of cross-reactive allergens is com-
monly represented in grass species, including BGP.
Moreover, we did not find patients with IgE positive
results to BGP yet TGP negative results, nor patients
with higher BGP IgE than TGP IgE. Therefore, in the
present observation BGP positive patients were in re-
ality sensitised to TGP. BGP-IgE levels were compa-
rable with TGP-IgE levels in those subjects co-
sensitised to calcium binding protein (Phl p 7) andor
profilin (Phl p 12). A previous study showed that BGP
may contain up to 230 proteins, about 65 of which are
IgE binding proteins and some of these are either iso-
forms or degraded allergen products.5 Currently
extract-based diagnosis includes both BGP- and TGP-
extract (or a mixture of grasses) in standard panels of
allergens employed for allergy diagnosis. This is due
to the assumption that BGP allergens differ from
those contained in other grasses as previously indi-
cated.2,5 The consequence of co-sensitisation to fur-
ther allergens, other than allergen markers of genu-
ine sensitisation to grass species, may contribute to
an increase in the sum of single allergen-IgE values.
We can assume that the sum of single allergen-IgE
values from a given allergen source better reflects the
overall IgE binding to allergen epitopes than IgE
Rossi RE et al.
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Fig. 6 Single Phl p 1, 2, 4, 5, 6, 7, 11, 12 IgE variation by age in 411 Bermuda grass polen alergic patients.
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Fig. 7 Ratios for total IgE value and Cynodon dactylon extract (Cyn d E)-; Phleum pratense extract (Phl p E)-; and sum 
of rPhl p 1, rPhl p 2, nPhl 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, rPhl p 12 specific IgE-value in 411 Bermuda grass pol-
len alergic patients, ages shown by decades (y＝years).
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Table 2 Diferences among variables with age as evalu-
ated by analysis of variance (ANOVA)
p-valueVariable
 .007762Total IgE
 .000348Specific IgE to Cynodon dactylon extract
 .000000Specific IgE to Phleum pratense extract
 .000000Sum of P. pratense alergen IgE values
 .000000Specific IgE to Phl p 1
 .000378Specific IgE to Phl p 2
 .000001Specific IgE to Phl p 4
 .000000Specific IgE to Phl p 5
 .000107Specific IgE to Phl p 6
 .65625Specific IgE to Phl p 7
 .000048Specific IgE to Phl p 11
 .0321597Specific IgE to Phl p 12
Table 3 Prevalence of the two most common specific IgE profiles shown by age in two sub-groups of patients sensitised to 
Bermuda grass living in the province of Cuneo, Italy.
＞50＜61
yrs
＞40＜51
yrs
＞30＜41
yrs
＞20＜31
yrs
＞10＜21
yrs
＜11
yrsMain IgE sensitisation profiles
23.1%
N＝3
13.6%
N＝3
15.9%
N＝10
16.1%
N＝15
30.1%
N＝37
31.0%
N＝27
Phl p 1＋ Phl p 2＋ Phl p 4＋ Phl p 5＋
Phl p 6＋ Phl p 7－ Phl p 11＋ Phl p 12－
 7.7%
N＝1
22.7%
N＝5
20.6%
N＝13
24.7%
N＝23
28.5%
N＝35
12.6%
N＝11
Phl p 1＋ Phl p 2＋ Phl p 4＋ Phl p 5＋
Phl p 6＋ Phl p 7－ Phl p 11＋ Phl p 12＋
binding to crude allergen extract (with variable aller-
gen content), as we have observed through our evalu-
ation of the ratio between total IgE value and P.
pratense extract IgE, and between total IgE value and
the sum of P. pratense recombinant allergen IgE, re-
spectively. These data seem to suggest that the pa-
tient sensitised to BGP who simultaneously has posi-
tive CAP-results towards TGP-recombinant allergens
is suited to treatment with an allergen vaccine com-
posed of a comprehensive extract of P. pratense con-
taining all the relevant cross-reactive allergens to
which a patient is sensitised. In our study, it is note-
worthy that more than 72% of patients were co-
sensitised to Phl p 1, 2, 4, 5, 6 which are contained in
grass-pollen allergen-extract vaccines, as we have
previously shown.9,10 As established in a previous re-
port of total and specific IgE variation with age11 our
findings confirm the decrease of total and allergen
specific IgE with age. A curious exception is the per-
sistence of IgE antibodies toward Phl p 7 where sen-
sitisation seems to be unaffected by age. Previously
we demonstrated the lack of IgG antibodies specific
for Phl p 7 in Phl p 7-IgE negative patients treated
with grass pollen vaccine (only Phl p 7-IgE positive
patients produced significant titres of specific Phl p 7-
IgG4 antibodies after grass pollen vaccine).9 These
findings together with the present observations sug-
gest a possible association of Phl p 7 reactivity with
HLA class II phenotypes. As expected, the great ma-
jority of patients suffering from OAS were sensitised
to profilin contained in many vegetables and fruits. A
minority of patients were also co-sensitised to Bet v 1,
cross reacting with homologous allergens contained
in Rosaceae and Umbrelliferae plant foods.
It is important to remember that some T cell epi-
topes of BGP and TGP could be useful for immuno-
therapeutic strategies. It is well known that allergen
specific T cell response in one individual, which is de-
termined by T cell epitopes, depends on the intrinsic
characteristics of their sequence which allow their
binding to the MHC class II groove on antigen pre-
senting cells. Homologous allergens from different al-
lergen sources tend to display peptides which are im-
munologically dominant in relatively homogeneous
sites of the protein, usually corresponding to the
most conserved regions of the allergen. The mecha-
nism of cross-recognition by T-cell of determinants
belonging to different allergens has been de-
scribed.12,13 Kolbe et al. indicated previously that im-
munization with minute doses of antigen leads to the
production of antibodies with class-associated epitope
specificities (designated epitopes G for IgG and E for
IgE antibodies), and their study showed no class anti-
body competition. For IgG antibody production, G
epitopes were immunodominant and IgG antibodies
directed to E epitopes were produced only after im-
munization with an increased immunogen dose.14
This concept might be applied in the case of T epi-
topes as well, although IgG4 antibodies are shown to
be dynamic molecules, undergoing Fab arm ex-
change in vitro and in vivo.15
In conclusion our data show that all BGP-allergic
patients simultaneously exhibit higher IgE antibody
levels to recombinant and natural P. pratense aller-
gens as well as to crude TGP extract. This suggests
that when choosing an immunotherapeutic regimen
for BGP-sensitised patients (after establishing their
IgE profile via purified TGP-allergens), subcutaneous
or sublingual TGP-extract vaccines in appropriate
doses, in order to influence T epitope specificity,
might be beneficial. Though extremely uncommon,
in cases where a patient is exclusively BGP allergen-
sensitised, BGP-extract therapy is the appropriate
therapeutic response.
Rossi RE et al.
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